Saturday, September 24, 2022, 7:00 AM – 5:00 PM, OnAir Virtual Platform, Washington, DC

This annual educational symposium is proud to update our medical community on the state-of-the-art care of gastric cancer, and gastrointestinal stromal tumors while focusing on the importance of a multidisciplinary approach to the diagnosis and treatment of these rare and complicated disease entities. National and international renowned guest speakers and distinguished faculty, including those from MedStar Health and MedStar Georgetown Cancer Institute will discuss the significant roles of precision medicine, evolving new diagnostic modalities, immune, regional, and molecular targeted therapies, and the use of state-of-the art radiotherapeutics in these rare and complex cancers. This symposium will also highlight evolving role of cytoreductive surgery for advanced gastric cancer.

1. Discuss novel imaging techniques for gastric cancer and gastrointestinal stromal tumors.
2. Identify the diagnostic and therapeutic role of endoscopy in gastric cancer.
3. Recognize the importance of molecular markers and ct-DNA in the diagnosis and treatment of gastric cancer.
4. Utilize recommendations from current molecular targeted therapy and immunotherapies for gastric cancer, including controversial areas such as MSI-high gastric cancer.
5. Discuss the role of surgery in treating gastrointestinal stromal tumors.
6. Discuss the emerging roles of Precision Medicine in the selection of systemic and targeted therapies in gastrointestinal stromal tumors.
7. Recognize the role local treatment modalities (ablation, TACE, radiation therapy) in the treatment of gastrointestinal stromal tumors and gastric cancers.
8. Integrate a team-based approach in the care of patients with gastric cancer and gastrointestinal stromal tumors.
9. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with gastric cancer and gastrointestinal stromal tumors.